Intellectual Property India Publishes Patent Application for A Biologically Safe Injectable Phyto-Therapeutic Formulation Comprising Carica Papaya-Derived Extract, Azadirachta Indica And Curcuma Longa For Selective Induction Of Cytotoxicity In Breast Cancer Cell Line Mcf-7

MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202631124354 A) filed by C. V. Raman Global University on October 16, 2026, for A Biologically Safe Injectable Phyto-Therapeutic Formulation Comprising Carica Papaya-Derived Extract, Azadirachta Indica And Curcuma Longa For Selective Induction Of Cytotoxicity In Breast Cancer Cell Line Mcf-7.

Inventors include Dr. Neelanjana Choudhury; and Barsharani Sethi.

The application for the patent was published on October 30, 2026, under issue no. 44/2026.

Abstract: The present invention discloses an injectable phyto-therapeutic formulation for selective induction of cytotoxicity in the breast cancer cell line MCF-7. The formulation comprises a papaya-derived ...